与内源性类甲醇胺相比,异林在刺激β1AR-β-arrestin2相互作用方面显示出独特的激酶依赖性
Edda S F Matthees1, Luca E Kletzin1, Arnelle Löbbert2
1Institute for Molecular Cell Biology, Center for Molecular Biomedicine, Universitätsklinikum Jena, Friedrich-Schiller-Universität Jena, Hans-Knöll-Straße 2, Jena, Germany.
Molecular pharmacology
|May 12, 2025
概括
合成和天然的心脏药物触发不同的信号通路. 了解β1-上腺素受体调节中的这些差异是治疗心脏病的关键.
科学领域:
- 心血管药理学心血管药理学
- 分子药理学分子药理学
- 细胞信号传输 细胞信号传输
背景情况:
- β1-上腺素受体 (β1AR) 对心脏功能至关重要,其失调与心脏疾病有关.
- 与β1AR的β-arrestin相互作用对受体调节至关重要,但特定的激酶贡献仍然不清楚.
- 了解激素特异性信号传递对于开发向疗法至关重要.
研究的目的:
- 研究G蛋白结合受体激酶 (GRKs) 和蛋白激酶A (PKA) 在β-arrestin2招募和在β1AR刺激后转移到血膜 (PM) 中的作用.
- 为了比较合成 (异上腺素) 和内源性 (上腺素,上腺素) 激动剂在β1AR调节中的激酶依赖性.
- 为了阐明底层的分子机制激素特异性β1AR信号传递.
主要方法:
- 使用了GRK2/3/5/6淘汰细胞和PKA抑制剂H89.
- 采用基于生物发光共振能量转移 (BRET) 的测试来测量β-arrestin2招募和PM转移.
- 对比了异上腺素,上腺素和上腺素对β1AR信号传递的影响.
主要成果:
- 在异上腺素刺激时,GRKs显著影响了β-arrestin2转移到PM,但并没有直接对β1AR招募β-arrestin2.
- 抑制PKA会根据所涉及的特定GRK不同影响异上腺素的疗效和强度.
- 上腺素和上腺素没有这些依赖激酶的效应,这表明它们具有不同的信号机制.
- 通过NMR光谱数据表明β1AR构造变化的激素特异性差异.
结论:
- 合成和内源激动剂诱导不同的β1AR调节通路.
- 激酶参与对于异上腺素介导的β-arrestin2转位至关重要,但对于上腺素或上腺素至关重要.
- 这些发现强调了考虑β1AR信号传递中的联体特异机制对于心脏病治疗发展的重要性.
相关概念视频
Adrenergic Receptors: β Subtype
1.4K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.4K
cAMP-dependent Protein Kinase Pathways
6.0K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.0K
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
Amplifying Signals via Enzymatic Cascade
8.2K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.2K
Adrenergic Receptors: ɑ Subtype
1.3K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.3K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
656
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
656


